Identifying Breast Cancer-Related Transcripts Through Alternative Splicing
Author Information
Author(s): Elisa N Ferreira, Maria CR Rangel, Pedro F Galante, Jorge E de Souza, Gustavo C Molina, Sandro J de Souza, Dirce M Carraro
Primary Institution: Hospital A.C. Camargo, Fundação Antonio Prudente, São Paulo, Brazil
Hypothesis
Can alternative splicing-enriched cDNA libraries identify breast cancer-associated transcripts influenced by ERBB2 expression?
Conclusion
The study developed a method to explore alternative splicing in breast cancer, identifying transcripts that can serve as potential molecular markers.
Supporting Evidence
- The study identified 214 alternative splicing sequence-enriched tags (ASSETs) from the constructed libraries.
- A high success rate of RT-PCR validation (94.5%) was achieved for the identified AS transcripts.
- Two novel alternative splicing events were discovered and characterized.
Takeaway
The researchers found new ways to look at how genes can be switched on and off in breast cancer, which might help doctors find better tests and treatments.
Methodology
The study used alternative splicing-enriched cDNA libraries constructed from a breast cell line and tumor samples, followed by sequencing and validation of identified transcripts.
Potential Biases
There may be risks of bias due to the reliance on specific RNA sources and the potential for differential expression affecting validation.
Limitations
The study may have limitations in detecting low-abundance transcripts and potential biases in the representation of splicing variants.
Participant Demographics
The study involved a human breast cell line and a pool of 5 ERBB2 over-expressing breast tumor samples.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website